Latest Industry Insights
MALDI Imaging Empowers Omics in Spatial Context for Unprecedented Molecular Insight
In this article, we outline how researchers at the University of Maastricht have used a novel spatial omics workflow to uncover proteomic profiles in tumor subpopulations of breast cancer.
Shaping the Future of Organoid Research
Molecular Devices recently unveiled a brand new, first-of-its-kind Organoid Innovation Center. In this interview, Susan Murphy tells us more about the Center and discusses the advantages of automating organoid culturing and screening workflows.
Trends, Applications and Advances in Spatial Transcriptomics
In this interview, Dr George Emanuel discusses the power of spatial transcriptomic profiling and some of the biggest trends in the field.
Advancing Research of Inflammatory Intestinal Diseases
We spoke to Dr Lorna Ewart, Emulate’s executive vice president of science, to learn more about the limitations of traditional inflammatory intestinal disease models, what makes the Colon Intestine-Chip a more relevant model and how it can be used to investigate potential drug targets.
Harnessing T Cells To Detect Disease
In this interview, Dr Sudeb Dalai, senior medical director at Adaptive Biotechnologies, discusses the role that T-cell analysis may play in the diagnosis and treatment of diseases including SARS-CoV-2.
Minipig Study Tests Gene Therapy for Huntington's Disease
A new body of work published in Science Translational Medicine outlines the preclinical testing of a microRNA-based gene therapy for Huntington's disease – AMT-130 – in minipigs.
Bioprocessing and Bioproduction Trends in Cell and Gene Therapies
In this interview, Technology Networks spoke with Neal Goodwin, PhD, Chief Scientific Officer at Teknova, to learn more about current bioprocessing and bioproduction trends in the cell and gene therapy space. Goodwin also discusses the impact of the COVID-19 pandemic on the biopharmaceutical sector and highlights how the industry has united to contribute to the development of vaccines at this critical time.
Animal-Free Methods for Drug Safety Testing
Animal-free testing methods are being increasingly explored and implemented as an alternative to animal models, in efforts to provide a more accurate prediction of a drug candidate’s efficacy and safety. InSphero recently hosted a virtual roundtable discussion on the topic of animal-free testing. Technology Networks had the pleasure of speaking with Armin Wolf, chief scientific officer at InSphero, to learn more about the topics discussed.
A Skin Test To Measure T-Cell Immunity to SARS-CoV-2
Technology Networks recently had the pleasure of speaking to Seth Lederman, president and chief executive officer of Tonix Pharmaceuticals, to learn more about the T-cell response to SARS-CoV-2, how it compares to the antibody response and the importance of measuring it during the pandemic.
An Automated Age for Western Blotting
Western blotting has been a core technique in molecular biology for many years, however, optimization and reproducibility can be problematic. We spoke to Dr Alexandre Lucas about the automation of western blotting and the difference this advance is making to research.